Copyright
©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 103830
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.103830
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.103830
Figure 2 Comprehensive evaluation of the mRNA expression and discernibility ability of homeobox C6 in bladder cancer based on global microarray data.
A: Forest plot of the homeobox C6 (HOXC6) standardized mean difference in bladder cancer; B: Publication bias by funnel plots of Egger’s test; C: The summary receiver operating characteristic curve of HOXC6. AUC: Area under the curve; SROC: Summary receiver operating characteristic curve; SMD: Standardized mean difference; BLCA: Bladder cancer.
- Citation: Lu DJ, Wang HR, Xu YS, Huang HB, Zhong QG, Luo YN, Qi JF, Wu HC, Pei JY, Zhang K, Xu CX, Wang TX, Zhang W, Zhou YH, Huang ZG, Wang FB. Homeobox C6 plays an oncogenic role in bladder cancer. World J Clin Oncol 2025; 16(5): 103830
- URL: https://www.wjgnet.com/2218-4333/full/v16/i5/103830.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i5.103830